Preoperative Optimization of Crohn Disease

被引:18
作者
Sharma, Amit [1 ]
Chinn, Bertram T. [1 ]
机构
[1] Univ Med & Dent, Div Colon & Rectal Surg, Robert Wood Johnson Med Sch, Edison, NJ 08820 USA
关键词
Crohn disease; immunomodulators; biologic therapy; steroids; nutrition; INFLAMMATORY-BOWEL-DISEASE; INTRAABDOMINAL SEPTIC COMPLICATIONS; EARLY POSTOPERATIVE COMPLICATIONS; RISK-FACTORS; ELEMENTAL DIET; PERCUTANEOUS DRAINAGE; MULTIVARIATE-ANALYSIS; NUTRITIONAL THERAPY; ENTERAL NUTRITION; RESECTION;
D O I
10.1055/s-0033-1348044
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Crohn disease is a chronic disease that is treated with aminosalicylates, antibiotics, and immunosuppressant agents. Most patients ultimately require surgical intervention and many will require additional surgery for recurrent disease. Consequently, surgery is generally performed only when medical management fails; however, these patients are often malnourished and immunosuppressed. Preoperative optimization is necessary to minimize morbidity, including intra-abdominal septic complications and anastomotic leaks. In this article, the authors review some considerations to improve the surgical outcome in Crohn disease.
引用
收藏
页码:75 / 79
页数:5
相关论文
共 65 条
[1]   Corticosteroids and immunomodulators: Postoperative infectious complication risk in inflammatory bowel disease patients [J].
Aberra, FN ;
Lewis, JD ;
Hass, D ;
Rombeau, JL ;
Osborne, B ;
Lichtenstein, GR .
GASTROENTEROLOGY, 2003, 125 (02) :320-327
[2]   ADRENOCORTICAL RESPONSIVENESS AFTER ALTERNATE-DAY CORTICOSTEROID THERAPY [J].
ACKERMAN, GL ;
NOLAN, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (08) :405-&
[3]  
ALLARDYCE DB, 1978, AM SURGEON, V44, P510
[4]   Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn's disease: A multivariate analysis in 161 consecutive patients [J].
Alves, Arnaud ;
Panis, Yves ;
Bouhnik, Yoram ;
Pocard, Marc ;
Vicaut, Eric ;
Valleur, Patrice .
DISEASES OF THE COLON & RECTUM, 2007, 50 (03) :331-336
[5]   Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients [J].
Appau, Kweku A. ;
Fazio, Victor W. ;
Shen, Bo ;
Church, James M. ;
Lashner, Bret ;
Remzi, Feza ;
Brzezinski, Aaron ;
Strong, Scott A. ;
Hammel, Jeffrey ;
Kiran, Ravi P. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2008, 12 (10) :1738-1744
[6]  
Badia-Tahull MB., 2009, E SPEN EUR J CLIN NU, V4, pe248, DOI [10.1016/j.eclnm.2009.07.001, DOI 10.1016/J.ECLNM.2009.07.001]
[7]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[8]  
Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430
[9]   Preoperative steroid administration: Effect on morbidity among patients undergoing intestinal bowel resection for Crohn's disease [J].
Bruewer, M ;
Utech, M ;
Rijcken, EJM ;
Anthoni, C ;
Laukoetter, MG ;
Kersting, S ;
Senninger, N ;
Krieglstein, CF .
WORLD JOURNAL OF SURGERY, 2003, 27 (12) :1306-1310
[10]   Surgical resection in Crohn's disease: is immunosuppressive medication associated with higher postoperative infection rates? [J].
Canedo, J. ;
Lee, S. -H. ;
Pinto, R. ;
Murad-Regadas, S. ;
Rosen, L. ;
Wexner, S. D. .
COLORECTAL DISEASE, 2011, 13 (11) :1294-1298